GUBBA PHARMA IN E NEWS

Read More

Pharma takes Wi-Fi targeting to the doctor’s office to reach waiting patients on their smartphones

July 17, 2019 Gubba Pharma In E News

Checking your phone at the doctor’s office? Don’t be surprised if you get an ad for a drug you can talk to your doctor about....

Continue Reading

Read More

German Study Finds Most New Drugs Fail to Improve on Standard of Care

July 17, 2019 Gubba Pharma In E News

A study in The BMJ by officials from Germany’s Institute of Quality and Efficiency in Healthcare (IQWiG) finds there is no evidence of added benefit...

Continue Reading

Read More

Dr Reddy’s plan to launch value-added drugs in US

July 17, 2019 Gubba Pharma In E News

Dr Reddy’s Laboratories said that it plans to launch several value-added products, to offset the persisting pricing pressure problem in the US market. As part...

Continue Reading

Read More

FDA Accepts Sanofi’s BLA for Meningitis Vaccine to Review

July 10, 2019 Gubba Pharma In E News

Sanofi SNY announced that the FDA has accepted for review its biologics license application (BLA) for MenQuadfi, a meningococcal vaccine candidate, currently being developed for...

Continue Reading

Read More

Maersk Spot unveiled as Danish carrier moves ahead with online box bookings

June 27, 2019 Gubba Pharma In E News

Maersk today unveiled the next chapter in its quest to lead liner shipping’s path to online container bookings. With the launch of Maersk Spot, the...

Continue Reading

Read More

AbbVie to acquire Botox maker Allergan for $63bn

June 27, 2019 Gubba Pharma In E News

US drugmaker AbbVie has agreed to buy Allergan, the Irish-domiciled maker of Botox, in a $63bn deal that is the sector’s latest blockbuster transaction driven...

Continue Reading

Read More

Bharat Biotech to collaborate with Hilleman to develop cholera vaccine

June 27, 2019 Gubba Pharma In E News

Hilleman Laboratories announced on Wednesday that it will collaborate with Hyderabad-based vaccine maker Bharat Biotech International Limited (BBIL) for further development, manufacture and commercialisation of...

Continue Reading

Read More

DuPont, BioMe Oxford to co-develop and bring to market smart capsule to sample gut microbiota

June 19, 2019 Gubba Pharma In E News

Intestinal microbiome, 3D illustration showing anatomy of human digestive system and enteric bacteria Escherichia coli, E. coli, colonizing jejunum, ileum, other parts of intestine. Gut...

Continue Reading

Read More

Pfizer opens new biologics clinical manufacturing facility in Massachusetts

June 12, 2019 Gubba Pharma In E News

Pfizer’s Andover site houses commercial manufacturing and product development functions, with colleagues dedicated to the development and production of high-quality complex biologics and vaccines. With...

Continue Reading